Arachidonate 5-lipoxygenase (ALOX5) |
5-aminosalicylic acid, sulfasalazine |
(70) |
Tumor necrosis factor alpha (TNFα) |
Sulfasalazine |
(67) |
Cyclooxygenase-1 (COX-1) |
Aspirin |
(63, 71) |
Cyclooxygenase-2 (COX-2) |
Aspirin, sodium salicylate |
(63, 71, 72) |
Nuclear factor-kappaB (NF-κB) |
Aspirin, sodium salicylate |
(69) |
Cathepsin A (CTSA) |
Aspirin |
(73) |
Inhibitor of nuclear factor-kappa-B kinase subunit beta (Iκκ-β) |
Aspirin, sodium salicylate |
(68) |
Ribosomal S6 kinase 2 (RSK2) |
Aspirin, salicylic acid |
(74) |
Adenosine monophosphate-activated protein kinase (AMPK) |
Sodium salicylate |
(75) |
Peroxisome proliferator-activated receptor gamma (PPARγ) |
Amorfrutins |
(17) |
Ferrochelatase (FECH) |
Salicylic acid |
(76) |
Acetyltransferase p300 (P300) |
Salsalate, salicylate |
(77) |
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) |
Salicylic acid, amorfrutins B1 and FN2, acetyl 3-aminoethyl salicylic acid, 5-aminosalicylic acid |
(14) |
High mobility group box 1 (HMGB1) |
Salicylic acid, amorfrutin B1, acetyl 3-aminoethyl salicylic acid |
(15) |
Cyclin-dependent kinase 2 (CDK2) |
Aspirin, salicylic acid |
(78) |